EverHeart Systems dba Corvion has filed a notice of an exempt offering of securities to raise $12,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, EverHeart Systems dba Corvion is raising up to $12,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Greg Aber played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About EverHeart Systems dba Corvion
Corvion is a pre-clinical stage medical device company focused on bringing fully implanted heart assist technology to the worldwide market for mechanical circulatory support. By developing a highly efficient implantable rotary blood pump (3X more efficient than competitors) coupled with a robust and flexible transcutaneous (through the skin) charging technology, the company aims to dramatically improve patient outcomes and quality of life.
To learn more about EverHeart Systems dba Corvion, visit http://corvion.com/
Contact:
Greg Aber, Chief Executive Officer
281-724-9647
https://www.linkedin.com/in/greg-aber-b0802931/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.